JENBURKT PHARMACEUTICALS
Smallcap | BSE
Sector
Here's the live share price of Jenburkt Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0.01₹ 0.05
As on Oct 16, 2026, 04:01 PM IST
Source: Dion Global
Jenburkt Pharmaceuticals Price Performance
Today's LowToday's High
₹916.05₹952.45
₹916.05
52 Weeks' Low52 Weeks' High
₹880.10₹1,321.00
₹916.05
Open Price
₹942.00
Prev. Close
₹916.00
Volume
243
Source: Dion Global
Jenburkt Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Jenburkt Pharmaceuticals | -3.06 | -7.97 | -15.91 | -10.13 | -13.01 | 10.65 | 13.31 |
| Sun Pharmaceutical Industries | 0.18 | -5.04 | -9.74 | 3.95 | 6.04 | 15.75 | 16.08 |
| Divi's Laboratories | -1.14 | 0.22 | 25.96 | 46.41 | 39.74 | 36.09 | 11.54 |
| Torrent Pharmaceuticals | -2.15 | -5.45 | -8.85 | 9.71 | 29.05 | 33.62 | 24.00 |
| Zydus Lifesciences | 0.83 | 1.75 | -2.53 | 19.71 | 14.26 | 23.96 | 16.03 |
| Laurus Labs | 1.32 | 8.03 | 32.19 | 82.28 | 135.84 | 72.87 | 26.12 |
| Cipla | 1.67 | -2.56 | -7.31 | 7.66 | -15.53 | 4.40 | 7.95 |
| Dr. Reddy's Laboratories | 3.08 | 7.56 | 0.65 | 0.87 | -0.66 | 3.91 | 4.79 |
| Aurobindo Pharma | -1.63 | 1.08 | 7.14 | 19.66 | 50.00 | 22.19 | 18.22 |
| Mankind Pharma | -3.97 | 1.20 | -10.61 | 8.09 | -7.32 | 7.81 | 9.82 |
| Lupin | -0.21 | -4.46 | -21.77 | -15.93 | 0.27 | 17.74 | 15.86 |
| Glenmark Pharmaceuticals | -2.94 | -7.63 | -2.78 | -1.14 | 19.23 | 40.76 | 33.75 |
| Alkem Laboratories | -4.00 | -2.59 | -11.38 | -9.22 | -8.48 | 11.88 | 5.53 |
| Biocon | 0.43 | -6.43 | -20.58 | -0.16 | -2.26 | 11.26 | 0.43 |
| Abbott India | 0.77 | 0.31 | -6.03 | 1.31 | -12.19 | 5.26 | 4.12 |
| Gland Pharma | -0.61 | 7.57 | 20.15 | 75.32 | 58.52 | 24.56 | -4.10 |
| Ipca Laboratories | -3.70 | -5.38 | -2.45 | 26.26 | 43.26 | 24.18 | 8.86 |
| Anthem Biosciences | -4.57 | -9.54 | 8.32 | 13.73 | 6.44 | 4.02 | 2.39 |
| GlaxoSmithKline Pharmaceuticals | 1.08 | -10.04 | 2.42 | 6.12 | -5.91 | 18.58 | 11.73 |
| Ajanta Pharma | -2.70 | -5.19 | -3.75 | 17.36 | 34.14 | 23.67 | 17.62 |
Source: Dion Global
Over the last one year, Jenburkt Pharmaceuticals has declined 13.01% compared to peers like Sun Pharmaceutical Industries (6.04%), Divi's Laboratories (39.74%), Torrent Pharmaceuticals (29.05%). From a 5 year perspective, Jenburkt Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (16.08%) and Divi's Laboratories (11.54%).
Jenburkt Pharmaceuticals Financials
Source: Dion Global
Jenburkt Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 929.5 | 921.13 |
| 10 | 918.76 | 926.34 |
| 20 | 941.85 | 944.97 |
| 50 | 1,008.51 | 993 |
| 100 | 1,064.88 | 1,031.68 |
| 200 | 1,063.04 | 1,061.57 |
Source: Dion Global
Jenburkt Pharmaceuticals Share Holding Pattern
In the latest quarter, Jenburkt Pharmaceuticals remained same as its previous close in promoter holding, while DII stake decreased to 0.03%, FII holding unchanged at 0.00%, and public shareholding moved up to 53.34% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Jenburkt Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 12, 2026, 10:56 PM IST IST | Jenburkt Pharma. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Sep 22, 2026, 06:50 PM IST IST | Jenburkt Pharma. - Intimation Regarding Admission Of Equity Shares Of The Company Under 'Permitted To Trade' Category On Nati |
| Sep 18, 2026, 09:53 PM IST IST | Jenburkt Pharma. - Announcement under Regulation 30 (LODR)-Change in Management |
| Sep 05, 2026, 03:04 AM IST IST | Jenburkt Pharma. - Announcement under Regulation 30 (LODR)-Change in Directorate |
| Sep 05, 2026, 02:54 AM IST IST | Jenburkt Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
Source: Dion Global
About Jenburkt Pharmaceuticals
Jenburkt Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 10/06/1985 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24230MH1985PLC036541 and registration number is 036541. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 168.74 Cr. and Equity Capital is Rs. 4.41 Cr. for the Year ended 31/03/2026.
- IndustryPharmaceuticals
- AddressUnicon 14th Floor, Dattaji salvi Marg, Mumbai Maharashtra 400053
- Contact
Source: Dion Global
Management
- Mr. Ashish U BhutaChairman & Managing Director
- Mr. Dilip H BhutaWholeTime Director & CFO
- Mrs. Hina R MehtaInd. Non-Executive Director
- Mr. Sumit A ThakkarInd. Non-Executive Director
- Mr. Krishnan SubharamanInd. Non-Executive Director
- Mr. Pankaj A DantwalaInd. Non-Executive Director
FAQs on Jenburkt Pharmaceuticals Share Price
What is the share price of Jenburkt Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Jenburkt Pharmaceuticals is ₹916.05 as on Oct 16, 2026.
What kind of stock is Jenburkt Pharmaceuticals?
The Jenburkt Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Jenburkt Pharmaceuticals?
The market cap of Jenburkt Pharmaceuticals is ₹404.28 Cr as on Oct 16, 2026.
What are today's High and Low prices of Jenburkt Pharmaceuticals?
Today’s highest and lowest price of Jenburkt Pharmaceuticals are ₹952.45 and ₹916.05.
What are the 52 Week High and 52 Week Low of Jenburkt Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Jenburkt Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Jenburkt Pharmaceuticals is ₹1,321.00 and 52-week low of Jenburkt Pharmaceuticals is ₹880.10 as on Oct 16, 2026.
How has the Jenburkt Pharmaceuticals performed historically in terms of returns?
The Jenburkt Pharmaceuticals has shown returns of 0.01% over the past day, -7.97% for the past month, -15.91% over 3 months, -13.01% over 1 year, 10.65% across 3 years, and 13.31% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Jenburkt Pharmaceuticals?
P/E ratio of and PB ratio of Jenburkt Pharmaceuticals are 12.31 and 1.99 on Oct 16, 2026. While the company gives a dividend yield of 2.26 per annum.
Source: Dion Global
✕